BERRY GLOBAL GROUP, INC. - Quarter Report: 2023 April (Form 10-Q)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
| ☒ |
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
For the quarterly period ended April 1, 2023
OR
| ☐ |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF SECURITIES EXCHANGE ACT OF 1934
|
For the transition period from __________ to __________
Commission File Number 001-35672
BERRY GLOBAL GROUP, INC.
|
A Delaware corporation
|
101 Oakley Street, Evansville, Indiana, 47710
(812) 424-2904
|
IRS employer identification number
20-5234618
|
Securities registered pursuant to Section 12(b) of the Exchange Act:
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
|
Common Stock, $0.01 par value per share
|
BERY
|
New York Stock Exchange LLC
|
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934
during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of
Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an
emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
|
Large Accelerated Filer ☒
|
Accelerated Filer ☐
|
Non-Accelerated Filer ☐
|
Smaller Reporting Company ☐
|
Emerging Growth Company ☐
|
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or
revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
There were 119.2 million shares of common stock
outstanding at May 4, 2023.
CAUTIONARY STATEMENT CONCERNING FORWARD-LOOKING STATEMENTS
Information included or incorporated by reference in Berry Global Group, Inc.’s filings with
the U.S. Securities and Exchange Commission (the “SEC”) and press releases or other public statements contains or may contain forward-looking statements. This report includes “forward-looking” statements with respect to our financial
condition, results of operations and business and our expectations or beliefs concerning future events. These statements contain words such as “believes,” “expects,” “may,” “will,” “should,” “would,” “could,” “seeks,” “approximately,” “intends,”
“plans,” “estimates,” “project,” “outlook,” “anticipates” or “looking forward” or similar expressions that relate to our strategy, plans, intentions, or expectations. All statements we make relating to our estimated and projected earnings, margins,
costs, expenditures, cash flows, growth rates, and financial results or to our expectations regarding future industry trends are forward-looking statements. In addition, we, through our senior management, from time to time make forward-looking public
statements concerning our expected future operations and performance and other developments. These forward-looking statements are subject to risks and uncertainties that may change at any time, and, therefore, our actual results may differ materially
from those that we expected. All forward-looking statements are made only as of the date hereof, and we undertake no obligation to publicly update or revise any forward-looking statement as a result of new information, future events or otherwise,
except as otherwise required by law.
Additionally, we caution readers that the list of important factors discussed in our most
recent Form 10-K in the section titled “Risk Factors” and subsequent periodic reports filed with the SEC may not contain all of the material factors that are important to you. In addition, in light of these risks and uncertainties, the
matters referred to in the forward-looking statements contained in this report may not in fact occur. Accordingly, readers should not place undue reliance on those statements.
Form 10-Q Index
For Quarterly Period Ended April 1, 2023
|
Part I.
|
Financial Information
|
Page No.
|
|
|
Item 1.
|
Financial Statements:
|
||
|
4
|
|||
|
5
|
|||
|
6
|
|||
|
7
|
|||
|
8
|
|||
|
Item 2.
|
15
|
||
|
Item 3.
|
21
|
||
|
Item 4.
|
21
|
||
|
Part II.
|
Other Information
|
||
|
Item 1.
|
22
|
||
|
Item 1A.
|
22
|
||
|
Item 2.
|
22
|
||
|
Item 6.
|
23
|
||
|
24
|
|||
Part I. Financial Information
| Item 1. |
Financial Statements
|
Consolidated Statements of Income
(Unaudited)
(in millions of dollars, except per share amounts)
|
Quarterly Period Ended
|
Two Quarterly Periods Ended
|
|||||||||||||||
|
April 1, 2023
|
April 2, 2022
|
April 1, 2023
|
April 2, 2022
|
|||||||||||||
|
Net sales
|
$
|
3,288
|
$
|
3,775
|
$
|
6,348
|
$
|
7,348
|
||||||||
|
Costs and expenses:
|
||||||||||||||||
|
Cost of goods sold
|
2,682
|
3,154
|
5,224
|
6,192
|
||||||||||||
|
Selling, general and administrative
|
220
|
207
|
456
|
442
|
||||||||||||
|
Amortization of intangibles
|
60
|
65
|
120
|
133
|
||||||||||||
|
Restructuring and transaction activities
|
25
|
8
|
37
|
11
|
||||||||||||
|
Operating income
|
301
|
341
|
511
|
570
|
||||||||||||
|
Other expense
|
1
|
6
|
2
|
6
|
||||||||||||
|
Interest expense
|
79
|
71
|
150
|
142
|
||||||||||||
|
Income before income taxes
|
221
|
264
|
359
|
422
|
||||||||||||
|
Income tax expense
|
47
|
59
|
79
|
96
|
||||||||||||
|
Net income
|
$
|
174
|
$
|
205
|
$
|
280
|
$
|
326
|
||||||||
|
Net income per share:
|
||||||||||||||||
|
Basic
|
$
|
1.44
|
$
|
1.53
|
$
|
2.29
|
$
|
2.42
|
||||||||
|
Diluted
|
1.42
|
1.50
|
2.27
|
2.36
|
||||||||||||
Consolidated Statements of Comprehensive Income
(Unaudited)
(in millions of dollars)
|
Quarterly Period Ended
|
Two Quarterly Periods Ended
|
|||||||||||||||
|
April 1, 2023
|
April 2, 2022
|
April 1, 2023
|
April 2, 2022
|
|||||||||||||
|
Net income
|
$
|
174
|
$
|
205
|
$
|
280
|
$
|
326
|
||||||||
|
Other comprehensive income, net of tax:
|
||||||||||||||||
|
Currency translation
|
60
|
37
|
201
|
15
|
||||||||||||
|
Derivative instruments
|
(31
|
)
|
71
|
(32
|
)
|
100
|
||||||||||
|
Other comprehensive income
|
29
|
108
|
169
|
115
|
||||||||||||
|
Comprehensive income
|
$
|
203
|
$
|
313
|
$
|
449
|
$
|
441
|
||||||||
See notes to consolidated financial statements.
Consolidated Balance Sheets
(in millions of dollars)
|
April 1, 2023
|
October 1, 2022
|
|||||||
|
(Unaudited)
|
||||||||
|
Assets
|
||||||||
|
Current assets:
|
||||||||
|
Cash and cash equivalents
|
$
|
696
|
$
|
1,410
|
||||
|
Accounts receivable
|
1,751
|
1,777
|
||||||
|
Finished goods
|
1,128
|
1,010
|
||||||
|
Raw materials and supplies
|
736
|
792
|
||||||
|
Prepaid expenses and other current assets
|
220
|
175
|
||||||
|
Total current assets
|
4,531
|
5,164
|
||||||
|
Noncurrent assets:
|
||||||||
|
Property, plant and equipment
|
4,612
|
4,342
|
||||||
|
Goodwill and intangible assets
|
6,866
|
6,685
|
||||||
|
Right-of-use assets
|
507
|
521
|
||||||
|
Other assets
|
97
|
244
|
||||||
|
Total assets
|
$
|
16,613
|
$
|
16,956
|
||||
|
Liabilities and stockholders’ equity
|
||||||||
|
Current liabilities:
|
||||||||
|
Accounts payable
|
$
|
1,350
|
$
|
1,795
|
||||
|
Accrued employee costs
|
243
|
253
|
||||||
|
Other current liabilities
|
715
|
783
|
||||||
|
Current portion of long-term debt
|
12
|
13
|
||||||
|
Total current liabilities
|
2,320
|
2,844
|
||||||
|
Noncurrent liabilities:
|
||||||||
|
Long-term debt
|
9,295
|
9,242
|
||||||
|
Deferred income taxes
|
575
|
707
|
||||||
|
Employee benefit obligations
|
162
|
160
|
||||||
|
Operating lease liabilities
|
414
|
429
|
||||||
|
Other long-term liabilities
|
552
|
378
|
||||||
|
Total liabilities
|
13,318
|
13,760
|
||||||
|
Stockholders’ equity:
|
||||||||
|
Common stock (119.2 and 124.2 million shares issued, respectively)
|
1
|
1
|
||||||
|
Additional paid-in capital
|
1,214
|
1,177
|
||||||
|
Retained earnings
|
2,314
|
2,421
|
||||||
|
Accumulated other comprehensive loss
|
(234
|
)
|
(403
|
)
|
||||
|
Total stockholders’ equity
|
3,295
|
3,196
|
||||||
|
Total liabilities and stockholders’ equity
|
$
|
16,613
|
$
|
16,956
|
||||
See notes to consolidated financial statements.
Consolidated Statements of Cash Flows
(Unaudited)
(in millions of dollars)
|
Two Quarterly Periods Ended
|
||||||||
|
April 1, 2023
|
April 2, 2022
|
|||||||
|
Cash Flows from Operating Activities:
|
||||||||
|
Net income
|
$
|
280
|
$
|
326
|
||||
|
Adjustments to reconcile net cash from operating activities:
|
||||||||
|
Depreciation
|
279
|
284
|
||||||
|
Amortization of intangibles
|
120
|
133
|
||||||
|
Non-cash interest (income) expense, net
|
(27
|
)
|
8
|
|||||
|
Settlement of derivatives
|
36
|
—
|
||||||
|
Deferred income tax
|
(51
|
)
|
(43
|
)
|
||||
|
Share-based compensation expense
|
30
|
28
|
||||||
|
Other non-cash operating activities, net
|
8
|
(14
|
)
|
|||||
|
Changes in working capital
|
(495
|
)
|
(714
|
)
|
||||
|
Changes in other assets and liabilities
|
(12
|
)
|
(22
|
)
|
||||
|
Net cash from operating activities
|
168
|
(14
|
)
|
|||||
|
Cash Flows from Investing Activities:
|
||||||||
|
Additions to property, plant and equipment, net
|
(385
|
)
|
(367
|
)
|
||||
|
Acquisition of a business and other
|
(88
|
)
|
3
|
|||||
|
Net cash from investing activities
|
(473
|
)
|
(364
|
)
|
||||
|
Cash Flows from Financing Activities:
|
||||||||
|
Proceeds from long-term borrowings
|
500
|
244
|
||||||
|
Repayments on long-term borrowings
|
(583
|
)
|
(9
|
)
|
||||
|
Proceeds from issuance of common stock
|
18
|
22
|
||||||
|
Repurchase of common stock
|
(333
|
)
|
(351
|
)
|
||||
|
Dividends paid
|
(65
|
)
|
—
|
|||||
|
Other, net
|
11
|
—
|
||||||
|
Net cash from financing activities
|
(452
|
)
|
(94
|
)
|
||||
|
Effect of currency translation on cash
|
43
|
3
|
||||||
|
Net change in cash and cash equivalents
|
(714
|
)
|
(469
|
)
|
||||
|
Cash and cash equivalents at beginning of period
|
1,410
|
1,091
|
||||||
|
Cash and cash equivalents at end of period
|
$
|
696
|
$
|
622
|
||||
See notes to consolidated financial statements.
Consolidated Statements of Changes in Stockholders’ Equity
(Unaudited)
(in millions of dollars)
|
Quarterly Period Ended
|
Common
Stock
|
Additional
Paid-in Capital
|
Accumulated Other
Comprehensive Loss
|
Retained
Earnings
|
Total
|
|||||||||||||||
|
Balance at December 31, 2022
|
$
|
1
|
$
|
1,199
|
$
|
(263
|
)
|
$
|
2,322
|
$
|
3,259
|
|||||||||
|
Net income
|
—
|
—
|
—
|
174
|
174
|
|||||||||||||||
|
Other comprehensive income
|
—
|
—
|
29
|
—
|
29
|
|||||||||||||||
|
Share-based compensation
|
—
|
7
|
—
|
—
|
7
|
|||||||||||||||
|
Proceeds from issuance of common stock
|
—
|
13
|
—
|
—
|
13
|
|||||||||||||||
|
Common stock repurchased and retired
|
—
|
(5
|
)
|
—
|
(150
|
)
|
(155
|
)
|
||||||||||||
|
Dividends paid
|
—
|
—
|
—
|
(32
|
)
|
(32
|
)
|
|||||||||||||
|
Balance at April 1, 2023
|
$
|
1
|
$
|
1,214
|
$
|
(234
|
)
|
$
|
2,314
|
$
|
3,295
|
|||||||||
|
Balance at January 1, 2022
|
$
|
1
|
$
|
1,170
|
$
|
(289
|
)
|
$
|
2,412
|
$
|
3,294
|
|||||||||
|
Net income
|
—
|
—
|
—
|
205
|
205
|
|||||||||||||||
|
Other comprehensive income
|
—
|
—
|
108
|
—
|
108
|
|||||||||||||||
|
Share-based compensation
|
—
|
7
|
—
|
—
|
7
|
|||||||||||||||
|
Proceeds from issuance of common stock
|
—
|
6
|
—
|
—
|
6
|
|||||||||||||||
|
Common stock repurchased and retired
|
—
|
(9
|
)
|
—
|
(291
|
)
|
(300
|
)
|
||||||||||||
|
Balance at April 2, 2022
|
$
|
1
|
$
|
1,174
|
$
|
(181
|
)
|
$
|
2,326
|
$
|
3,320
|
|||||||||
|
Two Quarterly Periods Ended
|
Common
Stock
|
Additional
Paid-in Capital
|
Accumulated Other
Comprehensive Loss
|
Retained
Earnings
|
Total
|
|||||||||||||||
|
Balance at October 1, 2022
|
$
|
1
|
$
|
1,177
|
$
|
(403
|
)
|
$
|
2,421
|
$
|
3,196
|
|||||||||
|
Net income
|
—
|
—
|
—
|
280
|
280
|
|||||||||||||||
|
Other comprehensive income
|
—
|
—
|
169
|
—
|
169
|
|||||||||||||||
|
Share-based compensation
|
—
|
30
|
—
|
—
|
30
|
|||||||||||||||
|
Proceeds from issuance of common stock
|
—
|
18
|
—
|
—
|
18
|
|||||||||||||||
|
Common stock repurchased and retired
|
—
|
(11
|
)
|
—
|
(322
|
)
|
(333
|
)
|
||||||||||||
|
Dividends paid
|
—
|
—
|
—
|
(65
|
)
|
(65
|
)
|
|||||||||||||
|
Balance at April 1, 2023
|
$
|
1
|
$
|
1,214
|
$
|
(234
|
)
|
$
|
2,314
|
$
|
3,295
|
|||||||||
|
Balance at October 2, 2021
|
$
|
1
|
$
|
1,134
|
$
|
(296
|
)
|
$
|
2,341
|
$
|
3,180
|
|||||||||
|
Net income
|
—
|
—
|
—
|
326
|
326
|
|||||||||||||||
|
Other comprehensive income
|
—
|
—
|
115
|
—
|
115
|
|||||||||||||||
|
Share-based compensation
|
—
|
28
|
—
|
—
|
28
|
|||||||||||||||
|
Proceeds from issuance of common stock
|
—
|
22
|
—
|
—
|
22
|
|||||||||||||||
|
Common stock repurchased and retired
|
—
|
(10
|
)
|
—
|
(341
|
)
|
(351
|
)
|
||||||||||||
|
Balance at April 2, 2022
|
$
|
1
|
$
|
1,174
|
$
|
(181
|
)
|
$
|
2,326
|
$
|
3,320
|
|||||||||
See notes to consolidated financial statements.
Notes to Consolidated Financial Statements
(Unaudited)
(tables in millions of dollars, except per share data)
1. Basis of Presentation
The accompanying unaudited Condensed Consolidated Financial Statements of Berry Global Group, Inc.
(“the Company,” “we,” or “Berry”) have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) pursuant to the rules and regulations of the Securities and Exchange Commission (the "SEC") for interim
reporting. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In preparing financial statements in conformity with GAAP, we must make estimates and assumptions that affect the reported amounts and disclosures at the date of the financial
statements and during the reporting period. Actual results could differ from those estimates. In the opinion of management, all adjustments (consisting of normal recurring
adjustments) considered necessary for a fair presentation have been included, and all subsequent events up to the time of the filing have been evaluated. For further information, refer to the Company’s most recent Form 10-K filed with the SEC.
2. Critical Accounting Policies and Recent Accounting Pronouncements
There have been no material changes in critical accounting policies from those described in our most recent Form 10-K.
Reference Rate Reform
In 2020, the FASB issued ASU 2020-04, Reference Rate Reform - Facilitation of the Effects of Reference Rate Reform on Financial Reporting (Topic 848). This
standard provides temporary optional expedients and exceptions to the GAAP guidance on contract modifications and hedge accounting to ease the financial reporting burdens of the expected market transition from LIBOR and other interbank offered rates to
alternative reference rates, such as SOFR. In 2022, the FASB issued ASU 2022-06, which deferred the sunset date of Topic 848 to December 31, 2024. The Company is evaluating timing of adoption, but does not expect a material change to our consolidated
financial statements or disclosures.
3. Revenue and Accounts Receivable
Our revenues are primarily derived from the sale of non-woven, flexible and rigid products to customers. Revenue is recognized when performance obligations
are satisfied, in an amount reflecting the consideration to which the Company expects to be entitled. We consider the promise to transfer products to be our sole performance obligation. If the consideration agreed to in a contract includes a variable
amount, we estimate the amount of consideration we expect to be entitled to in exchange for transferring the promised goods to the customer using the most likely amount
method. Our main source of variable consideration is customer rebates. There are no material instances where variable consideration is constrained and not recorded at the initial time of sale. Generally, our revenue is recognized at a point in
time for standard promised goods at the time of shipment, when title and risk of loss pass to the customer. The accrual for customer rebates was $95
million and $103 million at April 1, 2023
and October 1, 2022, respectively, and is included in Other current liabilities on the Consolidated Balance Sheets. The Company disaggregates
revenue based on reportable business segment, geography, and significant product line. Refer to Note 10. Segment and Geographic Data for further information.
Accounts receivable are presented net of allowance for credit losses of $18
million and $18 million at April 1, 2023
and October 1, 2022, respectively. The Company records its current expected credit losses based on a variety of factors including historical
loss experience and current customer financial condition. The changes to our current expected credit losses, write-off activity, and recoveries were not material for any of the periods presented.
The Company has entered into various factoring agreements, including customer-based supply chain financing programs, to sell certain receivables to
third-party financial institutions. Agreements which result in true sales of the transferred receivables, which occur when receivables are transferred without recourse to the Company, are reflected as a reduction of accounts receivable on the
consolidated balance sheets and the proceeds are included in the cash flows from operating activities in the consolidated statements of cash flows. The fees associated with the transfer of receivables for all programs were not material for any of the
periods presented.
4. Acquisition
Pro-Western Plastics
In March 2023, the Company acquired Pro-Western Plastics Ltd. (“Pro-Western”), a leading plastics injection molding company, for a purchase price of $88 million. The acquired business will be operated within the Consumer Packaging North America segment. To finance the purchase, the Company used existing
liquidity. The acquisition has been accounted for under the purchase method of accounting and accordingly, the purchase price has been allocated to the identifiable assets and liabilities based on preliminary values at the acquisition date. The
Company has recognized $35 million of goodwill on this transaction primarily as a result of expected cost synergies and expects goodwill to be
deductible for tax purposes.
5. Restructuring and Transaction Activities
The table below includes the significant components of our restructuring and transaction activities, by reporting
segment:
|
Quarterly Period Ended
|
Two Quarterly Periods Ended
|
|||||||||||||||
|
April 1, 2023
|
April 2, 2022
|
April 1, 2023
|
April 2, 2022
|
|||||||||||||
|
Consumer Packaging International
|
$
|
12
|
$
|
5
|
$
|
15
|
$
|
7
|
||||||||
|
Consumer Packaging North America
|
7
|
2
|
8
|
3
|
||||||||||||
|
Health, Hygiene & Specialties
|
5
|
—
|
8
|
(1
|
)
|
|||||||||||
|
Engineered Materials
|
1
|
1
|
6
|
2
|
||||||||||||
|
Consolidated
|
$
|
25
|
$
|
8
|
$
|
37
|
$
|
11
|
||||||||
The table below sets forth the activity with respect to the restructuring and transaction activities accrual at April 1, 2023:
|
Restructuring
|
||||||||||||||||||||
|
Employee
Severance
and Benefits
|
Facility
Exit Costs
|
Non-cash
Impairment
Charges
|
Transaction
Activities
|
Total
|
||||||||||||||||
|
Balance as of October 1, 2022
|
$
|
2
|
$
|
3
|
$
|
—
|
$
|
—
|
$
|
5
|
||||||||||
|
Charges
|
16
|
8
|
4
|
9
|
37
|
|||||||||||||||
|
Non-cash items
|
—
|
—
|
(4
|
)
|
—
|
(4
|
)
|
|||||||||||||
|
Cash
|
(5
|
)
|
(9
|
)
|
—
|
(9
|
)
|
(23
|
)
|
|||||||||||
|
Balance as of April 1, 2023
|
$
|
13
|
$
|
2
|
$
|
—
|
$
|
—
|
$
|
15
|
||||||||||
6. Leases
The Company leases certain manufacturing facilities, warehouses, office space, manufacturing equipment, office equipment, and automobiles.
Supplemental lease information is as follows:
|
Leases
|
Classification
|
April 1, 2023
|
October 1, 2022
|
||||||
|
Operating leases:
|
|||||||||
|
Operating lease right-of-use assets
|
|
$
|
507
|
$
|
521
|
||||
|
Current operating lease liabilities
|
|
109
|
108
|
||||||
|
Noncurrent operating lease liabilities
|
|
414
|
429
|
||||||
|
Finance leases:
|
|||||||||
|
Finance lease right-of-use assets
|
|
$
|
34
|
$
|
38
|
||||
|
Current finance lease liability
|
|
9
|
9
|
||||||
|
Noncurrent finance lease liabilities
|
|
21
|
24
|
||||||
7. Long-Term Debt
Long-term debt consists of the following:
|
Facility
|
Maturity Date
|
April 1, 2023
|
October 1, 2022
|
||||||
|
Term loan (a)
|
|
$
|
3,390
|
3,440
|
|||||
|
Revolving line of credit
|
|
—
|
—
|
||||||
|
0.95%
First Priority Senior Secured Notes (b)
|
|
279
|
800
|
||||||
|
1.00%
First Priority Senior Secured Notes (c)
|
|
761
|
686
|
||||||
|
1.57%
First Priority Senior Secured Notes
|
|
1,525
|
1,525
|
||||||
|
4.875%
First Priority Senior Secured Notes
|
|
1,250
|
1,250
|
||||||
|
1.65%
First Priority Senior Secured Notes
|
|
400
|
400
|
||||||
|
1.50%
First Priority Senior Secured Notes (c)
|
|
408
|
367
|
||||||
|
5.50%
First Priority Senior Secured Notes
|
|
500
|
—
|
||||||
|
4.50%
Second Priority Senior Secured Notes
|
|
291
|
298
|
||||||
|
5.625%
Second Priority Senior Secured Notes
|
|
500
|
500
|
||||||
|
Debt discounts and deferred fees
|
(42
|
)
|
(60
|
)
|
|||||
|
Finance leases and other
|
Various
|
45
|
49
|
||||||
|
Total long-term debt
|
9,307
|
9,255
|
|||||||
|
Current portion of long-term debt
|
(12
|
)
|
(13
|
)
|
|||||
|
Long-term debt, less current portion
|
$
|
9,295
|
9,242
|
||||||
| (a) |
Effectively 80% fixed interest rate with interest rate swaps (see Note 8).
|
| (b) |
Indicates debt which has been classified as long-term debt in accordance with the Company's ability and intention to refinance such obligations on a long-term basis.
|
| (c) |
Euro denominated
|
During the quarter ended April 1, 2023, the Company issued $500
million aggregate principal amount of 5.50% first priority senior secured notes due 2028. The proceeds were used to repurchase a portion of the
Company’s 0.95% first priority senior secured notes due 2024.
Debt discounts and deferred financing fees are presented net of Long-term debt, less the
current portion on the Consolidated Balance Sheets and are amortized to Interest expense, net on the Consolidated Statements of Income through maturity.
8. Financial Instruments and Fair Value Measurements
In the normal course of business, the Company is exposed to certain risks arising from business operations and economic factors. The Company may use
derivative financial instruments to help manage market risk and reduce the exposure to fluctuations in interest rates and foreign currencies. These financial instruments are not used for trading or other speculative purposes.
Cross-Currency Swaps
The Company is party to certain cross-currency swaps to hedge a portion of our foreign currency risk. The swap agreements mature June 2024 (€1,625 million) and July 2027 (£700 million). In
addition to cross-currency swaps, we hedge a portion of our foreign currency risk by designating foreign currency denominated long-term debt as net investment hedges of certain foreign operations. As of April 1, 2023, we had outstanding long-term debt of €785 million that
was designated as a hedge of our net investment in certain euro-denominated foreign subsidiaries. When valuing cross-currency swaps the Company utilizes Level 2 inputs (substantially observable).
Interest Rate Swaps
The primary purpose of the Company’s interest rate swap activities is to manage interest expense variability associated with our outstanding variable rate term loan debt. When valuing interest rate swaps the Company utilizes Level 2 inputs (substantially observable).
During fiscal 2023, the Company elected to cash settle existing interest rate swaps and received net proceeds of $36 million. The offset is included in Accumulated other comprehensive loss and is being amortized to Interest expense through the term of the original swaps. Following the
settlement, the Company entered into interest rate swaps with matching notional amounts with expiration in June 2026.
As of April 1, 2023, the Company effectively had
(i) a $450 million interest rate swap transaction that swaps a one-month variable LIBOR contract for a fixed annual rate of 4.128%, (ii) a $400 million interest rate swap transaction that swaps a one-month
variable LIBOR contract for a fixed annual rate of 4.522%, (iii) a $473 million interest rate swap transaction that swaps a one-month variable LIBOR
contract for a fixed annual rate of 3.961%, (iv) an $884 million interest rate swap transaction that swaps a one-month variable LIBOR
contract for a fixed annual rate of 4.522%, and (v) a $500 million interest rate swap transaction that swaps a one-month variable LIBOR
contract for a fixed annual rate of 3.672%. The Company's interest rate swap transactions all expire in June 2026.
The Company records the fair value positions of all derivative financial instruments on a
net basis by counterparty for which a master netting arrangement is utilized. Balances on a gross basis are as follows:
|
Derivative Instruments
|
Hedge Designation
|
Balance Sheet Location
|
April 1, 2023
|
October 1, 2022
|
||||||
|
Cross-currency swaps
|
Designated
|
Other assets
|
$
|
—
|
$
|
147
|
||||
|
Cross-currency swaps
|
Designated
|
Other long-term liabilities
|
125
|
—
|
||||||
|
Interest rate swaps
|
Designated
|
Other assets
|
1
|
11
|
||||||
|
Interest rate swaps
|
Designated
|
Other long-term liabilities
|
39
|
3
|
||||||
|
Interest rate swaps
|
Not designated
|
Other long-term liabilities
|
113
|
117
|
||||||
The effect of the Company’s derivative instruments on the Consolidated Statements of Income is as
follows:
|
Quarterly Period Ended
|
Two Quarterly Periods Ended
|
||||||||||||||||
|
Derivative Instruments
|
Statements of Income Location
|
April 1, 2023
|
April 2, 2022
|
April 1, 2023
|
April 2, 2022
|
||||||||||||
|
Cross-currency swaps
|
|
$
|
(10
|
)
|
$
|
(4
|
)
|
$
|
(21
|
)
|
$
|
(7
|
)
|
||||
|
Interest rate swaps
|
|
(11
|
)
|
12
|
(17
|
)
|
24
|
||||||||||
Non-recurring Fair Value Measurements
The Company has certain assets that are measured at fair value on a non-recurring basis when impairment indicators are present or when the Company completes
an acquisition. The Company adjusts certain long-lived assets to fair value only when the carrying values exceed the fair values. The categorization of the framework used to value the assets is considered Level 3, due to the subjective nature of the
unobservable inputs used to determine the fair value. These assets that are subject to our annual impairment analysis primarily include our definite lived and indefinite lived intangible assets, including Goodwill and our property, plant and
equipment. The Company reviews Goodwill and other indefinite lived assets for impairment as of the first day of the fourth fiscal quarter each year and more frequently if impairment indicators exist. The Company determined Goodwill and other
indefinite lived assets were not impaired in our annual fiscal 2022 assessment. No impairment indicators were identified in the current
quarter.
Included in the following table are the major categories of assets measured at fair value on a non-recurring
basis as of April 1, 2023 and October 1, 2022,
along with the impairment loss recognized on the fair value measurement during the period:
|
As of April 1, 2023
|
||||||||||||||||||||
|
Level 1
|
Level 2
|
Level 3
|
Total
|
Impairment
|
||||||||||||||||
|
Indefinite-lived trademarks
|
$
|
—
|
$
|
—
|
$
|
248
|
$
|
248
|
$
|
—
|
||||||||||
|
Goodwill
|
—
|
—
|
5,032
|
5,032
|
—
|
|||||||||||||||
|
Definite lived intangible assets
|
—
|
—
|
1,586
|
1,586
|
—
|
|||||||||||||||
|
Property, plant, and equipment
|
—
|
—
|
4,612
|
4,612
|
4
|
|||||||||||||||
|
Total
|
$
|
—
|
$
|
—
|
$
|
11,478
|
$
|
11,478
|
$
|
4
|
||||||||||
|
As of October 1, 2022
|
||||||||||||||||||||
|
Level 1
|
Level 2
|
Level 3
|
Total
|
Impairment
|
||||||||||||||||
|
Indefinite-lived trademarks
|
$
|
—
|
$
|
—
|
$
|
247
|
$
|
247
|
$
|
—
|
||||||||||
|
Goodwill
|
—
|
—
|
4,832
|
4,832
|
—
|
|||||||||||||||
|
Definite lived intangible assets
|
—
|
—
|
1,606
|
1,606
|
—
|
|||||||||||||||
|
Property, plant, and equipment
|
—
|
—
|
4,342
|
4,342
|
—
|
|||||||||||||||
|
Total
|
$
|
—
|
$
|
—
|
$
|
11,027
|
$
|
11,027
|
$
|
—
|
||||||||||
The Company’s financial instruments consist primarily of cash and cash equivalents, long-term
debt, interest rate and cross-currency swap agreements, and finance lease obligations. The book value of our marketable long-term indebtedness exceeded fair value by $336 million as of April 1, 2023.
The Company’s long-term debt fair values were determined using Level 2 inputs (substantially observable).
9. Income Taxes
On a year-to-date comparison to the statutory rate, the higher effective tax rate was negatively impacted by state taxes and global intangible low-taxed income provisions,
partially offset by other discrete items.
10. Segment and Geographic Data
The Company’s operations are organized into four
reporting segments: Consumer Packaging International, Consumer Packaging North America, Health, Hygiene & Specialties, and Engineered Materials. The structure is designed to align us
with our customers, provide optimal service, drive future growth, and to facilitate synergies realization.
Selected information by reportable segment is presented in the following tables:
|
Quarterly Period Ended
|
Two Quarterly Periods Ended
|
|||||||||||||||
|
April 1, 2023
|
April 2, 2022
|
April 1, 2023
|
April 2, 2022
|
|||||||||||||
|
Net sales:
|
||||||||||||||||
|
Consumer Packaging International
|
$
|
1,059
|
$
|
1,139
|
$
|
1,995
|
$
|
2,195
|
||||||||
|
Consumer Packaging North America
|
774
|
880
|
1,537
|
1,732
|
||||||||||||
|
Health, Hygiene & Specialties
|
677
|
822
|
1,340
|
1,640
|
||||||||||||
|
Engineered Materials
|
778
|
934
|
1,476
|
1,781
|
||||||||||||
|
Total net sales
|
$
|
3,288
|
$
|
3,775
|
$
|
6,348
|
$
|
7,348
|
||||||||
|
Operating income:
|
||||||||||||||||
|
Consumer Packaging International
|
$
|
75
|
$
|
97
|
$
|
121
|
$
|
166
|
||||||||
|
Consumer Packaging North America
|
93
|
85
|
164
|
131
|
||||||||||||
|
Health, Hygiene & Specialties
|
34
|
69
|
68
|
131
|
||||||||||||
|
Engineered Materials
|
99
|
90
|
158
|
142
|
||||||||||||
|
Total operating income
|
$
|
301
|
$
|
341
|
$
|
511
|
$
|
570
|
||||||||
|
Depreciation and amortization:
|
||||||||||||||||
|
Consumer Packaging International
|
$
|
77
|
$
|
82
|
$
|
151
|
$
|
164
|
||||||||
|
Consumer Packaging North America
|
54
|
53
|
105
|
107
|
||||||||||||
|
Health, Hygiene & Specialties
|
44
|
44
|
88
|
89
|
||||||||||||
|
Engineered Materials
|
25
|
27
|
55
|
57
|
||||||||||||
|
Total depreciation and amortization
|
$
|
200
|
$
|
206
|
$
|
399
|
$
|
417
|
||||||||
Selected information by geographical region is presented in the following tables:
|
Quarterly Period Ended
|
Two Quarterly Periods Ended
|
|||||||||||||||
|
April 1, 2023
|
April 2, 2022
|
April 1, 2023
|
April 2, 2022
|
|||||||||||||
|
Net sales:
|
||||||||||||||||
|
United States and Canada
|
$
|
1,751
|
$
|
1,996
|
$
|
3,447
|
$
|
3,948
|
||||||||
|
Europe
|
1,237
|
1,399
|
2,286
|
2,616
|
||||||||||||
|
Rest of world
|
300
|
380
|
615
|
784
|
||||||||||||
|
Total net sales
|
$
|
3,288
|
$
|
3,775
|
$
|
6,348
|
$
|
7,348
|
||||||||
11. Contingencies and Commitments
The Company is party to various legal proceedings involving routine claims which are incidental to its business. Although the Company’s legal and financial
liability with respect to such proceedings cannot be estimated with certainty, we believe that any ultimate liability would not be material to our financial position, results of operations or cash flows.
The Company has various purchase commitments for raw materials, supplies, and property and equipment incidental to the ordinary conduct of business.
12. Basic and Diluted Earnings Per Share
Basic net income or earnings per share ("EPS") is calculated by dividing the net income attributable to common stockholders by the weighted-average number of
common shares outstanding during the period, without consideration for common stock equivalents.
Diluted EPS includes the effects of options and restricted stock units, if dilutive.
The following tables provide a reconciliation of the numerator and denominator of the basic and diluted EPS calculations:
|
Quarterly Period Ended
|
Two Quarterly Periods Ended
|
|||||||||||||||
|
(in millions, except per share amounts)
|
April 1, 2023
|
April 2, 2022
|
April 1, 2023
|
April 2, 2022
|
||||||||||||
|
Numerator
|
||||||||||||||||
|
Consolidated net income
|
$
|
174
|
$
|
205
|
$
|
280
|
$
|
326
|
||||||||
|
Denominator
|
||||||||||||||||
|
Weighted average common shares outstanding - basic
|
120.7
|
133.8
|
122.2
|
134.6
|
||||||||||||
|
Dilutive shares
|
1.8
|
3.1
|
1.1
|
3.4
|
||||||||||||
|
Weighted average common and common equivalent shares outstanding - diluted
|
122.5
|
136.9
|
123.3
|
138.0
|
||||||||||||
|
Per common share earnings
|
||||||||||||||||
|
Basic
|
$
|
1.44
|
$
|
1.53
|
$
|
2.29
|
$
|
2.42
|
||||||||
|
Diluted
|
$
|
1.42
|
$
|
1.50
|
$
|
2.27
|
$
|
2.36
|
||||||||
1.2 million and 2.6 million shares were excluded from the diluted EPS calculation for the quarterly and two quarterly periods ended April 1, 2023 as their effect would be anti-dilutive. 1.2 million and 1.3 million shares were excluded
for the quarterly and two quarterly periods ended April 2, 2022.
13. Accumulated Other Comprehensive Loss
The components and activity of Accumulated other comprehensive loss are as follows:
|
Quarterly Period Ended
|
Currency
Translation
|
Defined Benefit
Pension and Retiree
Health Benefit Plans
|
Derivative
Instruments
|
Accumulated Other
Comprehensive Loss
|
||||||||||||
|
Balance at December 31, 2022
|
$
|
(314
|
)
|
$
|
(32
|
)
|
$
|
83
|
$
|
(263
|
)
|
|||||
|
Other comprehensive income (loss) before reclassifications
|
60
|
—
|
(21
|
)
|
39
|
|||||||||||
|
Net amount reclassified
|
—
|
—
|
(10
|
)
|
(10
|
)
|
||||||||||
|
Balance at April 1, 2023
|
$
|
(254
|
)
|
$
|
(32
|
)
|
$
|
52
|
$
|
(234
|
)
|
|||||
|
Currency
Translation
|
Defined Benefit
Pension and Retiree
Health Benefit Plans
|
Derivative
Instruments
|
Accumulated Other
Comprehensive Loss
|
|||||||||||||
|
Balance at January 1, 2022
|
$
|
(176
|
)
|
$
|
(67
|
)
|
$
|
(46
|
)
|
$
|
(289
|
)
|
||||
|
Other comprehensive income (loss) before reclassifications
|
37
|
—
|
69
|
106
|
||||||||||||
|
Net amount reclassified
|
—
|
—
|
2
|
2
|
||||||||||||
|
Balance at April 2, 2022
|
$
|
(139
|
)
|
$
|
(67
|
)
|
$
|
25
|
$
|
(181
|
)
|
|||||
|
Two Quarterly Periods Ended
|
Currency
Translation
|
Defined Benefit
Pension and Retiree
Health Benefit Plans
|
Derivative
Instruments
|
Accumulated Other
Comprehensive Loss
|
||||||||||||
|
Balance at October 1, 2022
|
$
|
(455
|
)
|
$
|
(32
|
)
|
$
|
84
|
$
|
(403
|
)
|
|||||
|
Other comprehensive income (loss) before reclassifications
|
201
|
—
|
(16
|
)
|
185
|
|||||||||||
|
Net amount reclassified
|
—
|
—
|
(16
|
)
|
(16
|
)
|
||||||||||
|
Balance at April 1, 2023
|
$
|
(254
|
)
|
$
|
(32
|
)
|
$
|
52
|
$
|
(234
|
)
|
|||||
|
Currency
Translation
|
Defined Benefit
Pension and Retiree
Health Benefit Plans
|
Derivative
Instruments
|
Accumulated Other
Comprehensive Loss
|
|||||||||||||
|
Balance at October 2, 2021
|
$
|
(154
|
)
|
$
|
(67
|
)
|
$
|
(75
|
)
|
$
|
(296
|
)
|
||||
|
Other comprehensive income (loss) before reclassifications
|
15
|
—
|
95
|
110
|
||||||||||||
|
Net amount reclassified
|
—
|
—
|
5
|
5
|
||||||||||||
|
Balance at April 2, 2022
|
$
|
(139
|
)
|
$
|
(67
|
)
|
$
|
25
|
$
|
(181
|
)
|
|||||
Executive Summary
Business. The Company’s operations are
organized into four operating segments: Consumer Packaging International, Consumer Packaging North America, Health, Hygiene & Specialties, and Engineered Materials. The structure is designed to align us with our customers, provide improved
service, drive future growth, and to facilitate synergies realization. The Consumer Packaging International segment primarily consists of closures and dispensing systems, pharmaceutical devices and packaging, bottles and canisters, and containers.
The Consumer Packaging North America segment primarily consists of containers and pails, foodservice, closures, bottles, prescription vials, and tubes. The Health, Hygiene & Specialties segment primarily consists of healthcare, hygiene,
specialties, and tapes. The Engineered Materials segment primarily consists of stretch and shrink films, converter films, institutional can liners, food and consumer films, retail bags, and agriculture films.
Raw Material Trends. Our primary raw material is polymer resin. In addition, we use other materials such as colorants, linerboard, and packaging materials in various manufacturing
processes. While temporary industry-wide shortages of raw materials have occurred, we have historically been able to manage the supply chain disruption by working closely with our suppliers and customers. Changes in the price of raw materials are
generally passed on to customers through contractual price mechanisms over time, during contract renewals and other means.
Outlook. The Company is affected by general economic and industrial growth, raw material availability, cost inflation, supply chain disruptions, and general industrial production. Our business has both
geographic and end market diversity, which reduces the effect of any one of these factors on our overall performance. Our results are affected by our ability to pass through raw material and other cost changes to our customers, improve manufacturing
productivity, and adapt to volume changes of our customers. Despite global macro-economic challenges in the short-term attributed to general market softness and continued inflation, particularly in Europe, we continue to believe our underlying
long-term demand fundamental in all divisions will remain strong as we focus on delivering protective solutions that enhance consumer safety and by providing advantaged products in targeted markets. For fiscal 2023, we project cash flow from operations between $1.4 to $1.5 billion and free cash flow between $800 to $900 million. Projected fiscal 2023 free cash flow assumes $600 million of capital spending. For the calculation of free cash flow and further information related to free cash flow as a non-GAAP financial
measure, see “Liquidity and Capital Resources.”
Results of Operations
Comparison of the Quarterly Period Ended April 1, 2023 (the “Quarter”) and the Quarterly Period Ended April 2, 2022 (the “Prior Quarter”)
Business integration expenses consist of restructuring and impairment charges, divestiture related costs, and other business optimization
costs. Tables present dollars in millions.
|
Consolidated Overview
|
||||||||||||||||
|
Quarter
|
Prior Quarter
|
$ Change
|
% Change
|
|||||||||||||
|
Net sales
|
$
|
3,288
|
$
|
3,775
|
$
|
(487
|
)
|
(13
|
)%
|
|||||||
|
Cost of goods sold
|
2,682
|
3,154
|
(472
|
)
|
(15
|
)%
|
||||||||||
|
Other operating expenses
|
305
|
280
|
25
|
9
|
%
|
|||||||||||
|
Operating income
|
$
|
301
|
$
|
341
|
$
|
(40
|
)
|
(12
|
)%
|
|||||||
Net Sales: The net sales decline is primarily attributed to a 6% volume decline, decreased selling prices of $143 million due to the pass-through of lower resin costs, an $80 million unfavorable impact from foreign currency changes, and
Prior Quarter divestiture sales of $42 million. The volume decline is primarily attributed to general market softness and ongoing inventory destocking.
Cost of goods sold: The cost of goods sold decrease is primarily
attributed to lower raw material prices, the volume decline, foreign currency changes, and Prior Quarter divestiture cost of goods sold.
Other operating expenses: The other operating expenses increase is
primarily attributed to an increase in business integration costs and selling, general, and administrative expenses.
Operating Income: The operating income decrease is primarily attributed to a $35 million unfavorable impact from the volume decline, an $18 million increase in business integration costs, a $15 million unfavorable impact from foreign currency changes, and an unfavorable impact
from increased selling, general, and administrative expenses. These declines are partially offset by a $40 million favorable impact from price cost spread as a result of cost reduction and improved product mix.
|
Consumer Packaging International
|
||||||||||||||||
|
Quarter
|
Prior Quarter
|
$ Change
|
% Change
|
|||||||||||||
|
Net sales
|
$
|
1,059
|
$
|
1,139
|
$
|
(80
|
)
|
(7
|
)%
|
|||||||
|
Operating income
|
$
|
75
|
$
|
97
|
$
|
(22
|
)
|
(23
|
)%
|
|||||||
Net Sales: The net sales decline in the Consumer Packaging
International segment is primarily attributed to a $57 million unfavorable impact from foreign currency changes, a 5% volume decline, and Prior Quarter divestiture sales of $42 million, partially offset by increased selling prices of $76 million due to
the pass-through of European inflation. The volume decline is primarily attributed to general market softness.
Operating Income: The operating income decrease is primarily attributed to a $10 million unfavorable impact from the volume decline, a $9 million
unfavorable impact from foreign currency changes, a $7 million unfavorable impact from increased business integration costs, and increased selling, general, and administrative expenses. These items are partially offset by a $10 million favorable impact from price cost spread.
|
Consumer Packaging North America
|
||||||||||||||||
|
Quarter
|
Prior Quarter
|
$ Change
|
% Change
|
|||||||||||||
|
Net sales
|
$
|
774
|
$
|
880
|
$
|
(106
|
)
|
(12
|
)%
|
|||||||
|
Operating income
|
$
|
93
|
$
|
85
|
$
|
8
|
9
|
%
|
||||||||
Net Sales: The net sales decline in the Consumer Packaging North
America segment is primarily attributed to decreased selling prices of $80 million and a 3% volume decline. The volume decline is primarily attributed to general market
softness partially offset by growth in our foodservice market.
Operating Income: The operating income increase is primarily attributed to a $24 million favorable impact from price cost spread, partially offset by unfavorable impacts from the volume decline, increased business integration costs,
and increased selling, general, and administrative expenses.
|
Health, Hygiene & Specialties
|
||||||||||||||||
|
Quarter
|
Prior Quarter
|
$ Change
|
% Change
|
|||||||||||||
|
Net sales
|
$
|
677
|
$
|
822
|
$
|
(145
|
)
|
(18
|
)%
|
|||||||
|
Operating income
|
$
|
34
|
$
|
69
|
$
|
(35
|
)
|
(51
|
)%
|
|||||||
Net Sales: The net sales decline in the Health, Hygiene & Specialties segment is primarily attributed to a 9% volume decline and decreased selling prices of $64 million. The volume decline is primarily attributed to general
market softness in our specialties markets and ongoing inventory destocking.
Operating Income: The operating income decrease is primarily
attributed to a $19 million unfavorable impact from price cost spread and a $9 million unfavorable impact from the volume decline.
|
Engineered Materials
|
||||||||||||||||
|
Quarter
|
Prior Quarter
|
$ Change
|
% Change
|
|||||||||||||
|
Net sales
|
$
|
778
|
$
|
934
|
$
|
(156
|
)
|
(17
|
)%
|
|||||||
|
Operating income
|
$
|
99
|
$
|
90
|
$
|
9
|
10
|
%
|
||||||||
Net Sales: The net sales decline in the Engineered Materials segment is primarily attributed to decreased selling prices of $75 million, a 7% volume decline, and a $16 million unfavorable impact from foreign currency changes. The
volume decline is primarily attributed to general market softness in European industrial markets and ongoing inventory destocking.
Operating Income: The operating income increase is primarily
attributed to a $25 million favorable impact from price cost spread, partially offset by an $11 million unfavorable impact from the volume decline.
|
Interest expense
|
||||||||||||||||
|
Quarter
|
Prior Quarter
|
$ Change
|
% Change
|
|||||||||||||
|
Interest expense
|
$
|
79
|
$
|
71
|
$
|
8
|
11
|
%
|
||||||||
The interest expense increase is primarily the
result of higher interest rates.
Changes in Comprehensive Income
The $110 million decline in comprehensive income from the Prior Quarter is primarily attributed to a $102 million unfavorable change in the fair value of derivative instruments, net of
tax, and a $31 million decline in
net income, partially offset by a $23 million favorable
change in currency translation. Currency translation changes are primarily related to non-U.S. subsidiaries with a functional currency other than the U.S. dollar whereby assets and liabilities are translated from the respective functional currency
into U.S. dollars using period-end exchange rates. The change in currency translation in the Quarter was primarily attributed to locations utilizing the Euro and British pound sterling as their functional currency. As part of the overall risk
management, the Company uses derivative instruments to (i) reduce our exposure to changes in interest rates attributed to the Company’s borrowings and (ii) reduce foreign currency exposure to translation of certain foreign operations. The Company
records changes to the fair value of these instruments in Accumulated other comprehensive loss. The change in fair value of these instruments in fiscal 2023
versus fiscal 2022 is primarily attributed to the change in the forward interest and foreign exchange curves between measurement dates.
Comparison of the Two Quarterly Periods Ended April 1, 2023 (the “YTD”) and the Two Quarterly Periods Ended April 2, 2022 (the “Prior YTD”)
Business integration expenses consist of restructuring and impairment charges, divestiture related costs, and other business optimization
costs. Tables present dollars in millions.
|
Consolidated Overview
|
||||||||||||||||
|
YTD
|
Prior YTD
|
$ Change
|
% Change
|
|||||||||||||
|
Net sales
|
$
|
6,348
|
$
|
7,348
|
$
|
(1,000
|
)
|
(14
|
)%
|
|||||||
|
Cost of goods sold
|
5,224
|
6,192
|
(968
|
)
|
(16
|
)%
|
||||||||||
|
Other operating expenses
|
613
|
586
|
27
|
5
|
%
|
|||||||||||
|
Operating income
|
$
|
511
|
$
|
570
|
$
|
(59
|
)
|
(10
|
)%
|
|||||||
Net Sales: The net sales decline is primarily attributed to a 6% volume decline, decreased selling prices of $286 million due to the pass-through of lower resin costs, a $188 million unfavorable impact from foreign currency changes, and
Prior YTD divestiture sales of $81 million. The volume decline is primarily attributed to general market softness and customer destocking as supply chains normalize.
Cost of goods sold: The cost of goods sold decrease is primarily
attributed to lower raw material prices, the volume decline, foreign currency changes, and Prior YTD divestiture cost of goods sold.
Other operating expenses: The other operating expenses increase is
primarily attributed to an increase in business integration costs.
Operating Income: The operating income decrease is primarily attributed to a $68 million unfavorable impact from the volume decline, a $37 million unfavorable impact from foreign currency changes, and a $26 million unfavorable
impact from increased business integration costs. These declines are partially offset by a $90 million favorable impact from price cost spread as a result of cost reduction and improved product mix.
|
Consumer Packaging International
|
||||||||||||||||
|
YTD
|
Prior YTD
|
$ Change
|
% Change
|
|||||||||||||
|
Net sales
|
$
|
1,995
|
$
|
2,195
|
$
|
(200
|
)
|
(9
|
)%
|
|||||||
|
Operating income
|
$
|
121
|
$
|
166
|
$
|
(45
|
)
|
(27
|
)%
|
|||||||
Net Sales: The net sales decline in the Consumer Packaging
International segment is primarily attributed to a $122 million unfavorable impact from foreign currency changes, a 5% volume decline, and Prior Quarter divestiture sales of $81 million, partially offset by increased selling prices of $116 million due
to the pass-through of European inflation. The volume decline is primarily attributed to general market softness.
Operating Income: The operating income decrease is primarily attributed to a $25 million unfavorable impact from foreign currency changes, a $20 million unfavorable impact from the volume decline, and an $8 million unfavorable impact from increased business integration costs. These declines are partially offset by a $16 million favorable impact from price cost spread.
|
Consumer Packaging North America
|
||||||||||||||||
|
YTD
|
Prior YTD
|
$ Change
|
% Change
|
|||||||||||||
|
Net sales
|
$
|
1,537
|
$
|
1,732
|
$
|
(195
|
)
|
(11
|
)%
|
|||||||
|
Operating income
|
$
|
164
|
$
|
131
|
$
|
33
|
25
|
%
|
||||||||
Net Sales: The net sales decline in the Consumer Packaging North
America segment is primarily attributed to decreased selling prices of $142 million and a 3% volume decline. The volume decline is primarily attributed to general market
softness partially offset by growth in our foodservice market.
Operating Income: The operating income increase is primarily
attributed to a $58 million favorable impact from price cost spread, partially offset by a $9 million unfavorable impact from the volume decline and an unfavorable impact from increased selling, general, and administrative expenses.
|
Health, Hygiene & Specialties
|
||||||||||||||||
|
YTD
|
Prior YTD
|
$ Change
|
% Change
|
|||||||||||||
|
Net sales
|
$
|
1,340
|
$
|
1,640
|
$
|
(300
|
)
|
(18
|
)%
|
|||||||
|
Operating income
|
$
|
68
|
$
|
131
|
$
|
(63
|
)
|
(48
|
)%
|
|||||||
Net Sales: The net sales decline in the Health, Hygiene & Specialties segment is primarily attributed to a 9% volume decline, decreased selling prices of $136 million, and a $25 million unfavorable impact from foreign currency
changes. The volume decline is primarily attributed to general market softness and customer destocking as supply chains normalize.
Operating Income: The operating income decrease is primarily
attributed to a $38 million unfavorable impact from price cost spread, a $17 million unfavorable impact from the volume decline, and an $8 million unfavorable impact from foreign currency changes.
|
Engineered Materials
|
||||||||||||||||
|
YTD
|
Prior YTD
|
$ Change
|
% Change
|
|||||||||||||
|
Net sales
|
$
|
1,476
|
$
|
1,781
|
$
|
(305
|
)
|
(17
|
)%
|
|||||||
|
Operating income
|
$
|
158
|
$
|
142
|
$
|
16
|
11
|
%
|
||||||||
Net Sales: The net sales decline in the Engineered Materials segment is primarily attributed to an 8% volume decline, decreased selling prices of $124 million, and a $41 million unfavorable impact from foreign currency changes. The
volume decline is primarily attributed to general market softness and customer destocking as supply chains normalize.
Operating Income: The operating income increase is primarily
attributed to a $54 million favorable impact from price cost spread, partially offset by a $22 million unfavorable impact from the volume decline, an unfavorable impact from increased selling, general, and administrative expenses, and an unfavorable
impact from increased business integration costs.
|
Interest expense
|
||||||||||||||||
|
YTD
|
Prior YTD
|
$ Change
|
% Change
|
|||||||||||||
|
Interest expense
|
$
|
150
|
$
|
142
|
$
|
8
|
6
|
%
|
||||||||
The interest expense increase is primarily the
result of higher interest rates.
Changes in Comprehensive Income
The $8 million improvement in comprehensive income from the Prior YTD was primarily attributed to a $186 million favorable change in currency translation, partially offset by a $132 million unfavorable change in the fair
value of derivative instruments, net of tax, and a $46 million decline in net income. Currency translation changes are primarily related to non-U.S. subsidiaries with a functional currency other than the U.S. dollar whereby assets and liabilities are
translated from the respective functional currency into U.S. dollars using period-end exchange rates. The change in currency translation in the YTD was primarily attributed to locations utilizing the Euro and British pound sterling as their functional
currency. As part of the overall risk management, the Company uses derivative instruments to (i) reduce our exposure to changes in interest rates attributed to the Company’s borrowings and (ii) reduce foreign currency exposure to translation of
certain foreign operations. The Company records changes to the fair value of these instruments in Accumulated other comprehensive loss. The change in fair value of these instruments in fiscal 2023 versus fiscal 2022 is primarily attributed to the change in the forward
interest and foreign exchange curves between measurement dates.
Liquidity and Capital Resources
Senior Secured Credit Facility
We manage our global cash requirements considering (i) available funds among the many subsidiaries through which we conduct business, (ii) the geographic
location of our liquidity needs, and (iii) the cost to access international cash balances. At the end of the Quarter, the Company had no
outstanding balance on its $1,050 million asset-based revolving line of credit that matures in May 2024. The Company was in compliance with all
covenants at the end of the Quarter.
Cash Flows
Net cash from operating activities increased $182 million from the Prior YTD primarily attributed to working capital improvement.
Net cash used in investing activities increased
$109 million from the Prior YTD primarily attributed to the acquisition of Pro-Western in the YTD.
Net cash used in financing activities increased
$358 million from the Prior YTD primarily attributed to higher repayments of long-term debt and initiation of a quarterly dividend in the YTD.
Dividend Payments
The Company declared and paid a cash dividend of $0.25 per share during both the first fiscal quarter that ended December 31, 2022 and the second fiscal
quarter that ended April 1, 2023.
Share Repurchases
YTD fiscal 2023, the Company repurchased
approximately 6 million shares for $333
million. Authorized share repurchases of $710 million remain available to the Company.
Free Cash Flow
Our consolidated free cash flow for the YTD and Prior YTD are summarized as follows:
|
April 1, 2023
|
April 2, 2022
|
|||||||
|
Cash flow from operating activities
|
$
|
168
|
$
|
(14
|
)
|
|||
|
Additions to property, plant and equipment, net
|
(385
|
)
|
(367
|
)
|
||||
|
Free cash flow
|
$
|
(217
|
)
|
$
|
(381
|
)
|
||
We use free cash flow as a supplemental measure of liquidity as it assists us in assessing our ability to fund growth through generation of cash. Free cash flow may be
calculated differently by other companies, including other companies in our industry or peer group, limiting its usefulness on a comparative basis. Free cash flow is not a financial measure presented in accordance with generally accepted accounting
principles ("GAAP") and should not be considered as an alternative to any other measure determined in accordance with GAAP.
Liquidity Outlook
At April 1, 2023, our cash balance was $696 million, which was primarily located outside the U.S. We believe our existing U.S. based cash and cash flow from U.S. operations, together with
available borrowings under our senior secured credit facilities, will be adequate to meet our short-term and long-term liquidity needs with the exception of funds needed to cover all long-term debt obligations, which we intend to refinance prior to
maturity. The Company has the ability to repatriate the cash located outside the U.S. to the extent not needed to meet operational and capital needs without significant restrictions.
Summarized Guarantor Financial Information
Berry Global, Inc. (“Issuer”) has notes outstanding which are fully, jointly, severally, and unconditionally guaranteed by its parent, Berry Global Group, Inc. (for purposes
of this section, “Parent”) and substantially all of Issuer’s domestic subsidiaries. Separate narrative information or financial statements of the guarantor subsidiaries have not been included because they are 100% owned by Parent and the guarantor
subsidiaries unconditionally guarantee such debt on a joint and several basis. A guarantee of a guarantor subsidiary of the securities will terminate upon the following customary circumstances: the sale of the capital stock of such guarantor if such
sale complies with the indentures, the designation of such guarantor as an unrestricted subsidiary, the defeasance or discharge of the indenture or in the case of a restricted subsidiary that is required to guarantee after the relevant issuance date,
if such guarantor no longer guarantees certain other indebtedness of Issuer. The guarantees of the guarantor subsidiaries are also limited as necessary to prevent them from constituting a fraudulent conveyance under applicable law and any guarantees
guaranteeing subordinated debt are subordinated to certain other of the Company’s debts. Parent also guarantees Issuer’s term loans and revolving credit facilities. The guarantor subsidiaries guarantee our term loans and are co-borrowers under our
revolving credit facility.
Presented below is summarized financial information for the Parent, Issuer and guarantor subsidiaries on a combined basis, after intercompany transactions have been
eliminated.
|
Two Quarterly Periods Ended
|
||||
|
April 1, 2023
|
||||
|
Net sales
|
$
|
3,346
|
||
|
Gross profit
|
653
|
|||
|
Earnings from continuing operations
|
231
|
|||
|
Net income
|
$
|
231
|
||
Includes $4 million of income associated with intercompany activity
with non-guarantor subsidiaries.
|
April 1, 2023
|
October 1, 2022
|
|||||||
|
Assets
|
||||||||
|
Current assets
|
$
|
1,618
|
$
|
2,432
|
||||
|
Noncurrent assets
|
5,961
|
6,137
|
||||||
|
Liabilities
|
||||||||
|
Current liabilities
|
$
|
915
|
$
|
1,536
|
||||
|
Intercompany payable
|
636
|
634
|
||||||
|
Noncurrent liabilities
|
10,676
|
10,630
|
||||||
Interest Rate Risk
We are exposed to market risk from changes in interest rates primarily through our senior secured credit facilities. Our senior secured credit facilities are
comprised of (i) $3.4 billion term loans and (ii) a $1,050
million revolving credit facility with no balance outstanding. Borrowings under our senior secured credit facilities bear interest at a rate
equal to an applicable margin plus LIBOR or SOFR. The applicable margin for borrowings under the revolving credit facility ranges from 1.25% to
1.50%, and the margin for term loans is 1.75%
per annum. As of period end, the LIBOR rate of approximately 4.86% was applicable to the term loans. For the portion of our term loans that
are not hedged by interest rate swaps, a 0.25% change in LIBOR would increase our annual interest expense by $2 million on variable rate term
loans.
We seek to minimize interest rate volatility risk through regular operating and financing activities and, when deemed appropriate, through the use of
derivative financial instruments. These financial instruments are not used for trading or other speculative purposes. (See Note 8.)
Foreign Currency Risk
As a global company, we face foreign currency risk exposure from fluctuating currency exchange rates, primarily the U.S. dollar against the euro, British
pound sterling, Brazilian real, Chinese renminbi, Canadian dollar and Mexican peso. Significant fluctuations in currency rates can have a substantial impact, either positive or negative, on our revenue, cost of sales, and operating expenses.
Currency translation gains and losses are primarily related to non-U.S. subsidiaries with a functional currency other than U.S. dollars whereby assets and liabilities are translated from the respective functional currency into U.S. dollars using
period-end exchange rates and impact our Comprehensive income. A 10% decline in foreign currency exchange rates would have had a $12 million
unfavorable impact on our Net income for the two quarterly periods ended April 1, 2023. (See Note 8.)
(a) Evaluation of disclosure controls and procedures.
Under applicable Securities and Exchange Commission regulations, management of a reporting company, with the participation of the principal executive officer
and principal financial officer, must periodically evaluate the company’s “disclosure controls and procedures,” which are defined generally as controls and other procedures of a reporting company designed to ensure that information required to be
disclosed by the reporting company in its periodic reports filed with the commission (such as this Form 10-Q) is recorded, processed, summarized, and reported on a timely basis.
The Company’s management, with the participation of the Chief Executive Officer and the Chief Financial Officer, carried out an evaluation of the
effectiveness of the design and operation of the disclosure controls and procedures as of the end of the period covered by this report. Based on this evaluation, our Chief Executive Officer and Chief Financial Officer concluded that the design and
operation of our disclosure controls and procedures were effective at the reasonable assurance level as of the end of the period covered by this report.
(b) Changes in internal control over financial reporting.
There were no changes in our internal control over financial reporting that occurred during the Quarter that have materially affected, or are reasonably
likely to materially affect, our internal control over financial reporting.
Part II. Other Information
There have been no material changes in legal proceedings from the items disclosed in our most recent Form 10-K filed with the Securities and Exchange
Commission.
Before investing in our securities, we recommend that investors carefully consider the risks described in our most recent Form 10-K and subsequent periodic
reports filed with the Securities and Exchange Commission, including those under the heading “Risk Factors” and other information contained in this Quarterly Report. Realization of any of these risks could have a material adverse effect on our
business, financial condition, cash flows and results of operations.
Additionally, we caution readers that the list of risk factors discussed in our most recent
Form 10-K and subsequent periodic reports may not contain all of the material factors that are important to you. In addition, in light of these risks and uncertainties, the matters referred to in the forward-looking statements contained in
this report may not in fact occur. Accordingly, readers should not place undue reliance on those statements.
Issuer Repurchases of Equity Securities
The following table summarizes the Company's repurchases of its common stock during the Quarterly Period ended April 1, 2023.
|
Fiscal Period
|
Total Number of
Shares Purchased
|
Average Price
Paid Per Share
|
Total Number of Shares
Purchased as Part of Publicly
Announced Programs
|
Dollar Value of Shares that
May Yet be Purchased Under
the Program (in millions) (a)
|
||||||||||||
|
January
|
80,000
|
$
|
64.50
|
80,000
|
$
|
859
|
||||||||||
|
February
|
1,519,597
|
62.50
|
1,519,597
|
764
|
||||||||||||
|
March
|
944,808
|
58.06
|
944,808
|
710
|
||||||||||||
|
Total
|
2,544,405
|
$
|
60.92
|
2,544,405
|
$
|
710
|
||||||||||
| (a) |
All open market purchases during the quarter were made under the 2023 authorization from our board of directors.
|
|
Exhibit No.
|
Description of Exhibit
|
|
|
Indenture, among Berry Global, Inc., certain guarantors party thereto, U.S. Bank Trust Company, National Association, as Trustee and Collateral Agent,
relating to the 5.50% First Priority Senior Secured Notes due 2028, dated March 30, 2023 (incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K filed on March 30, 2023).
|
||
|
Registration Rights Agreement, by and between Berry Global, Inc., Berry Global Group, Inc., each subsidiary of Berry Global, Inc. identified therein,
and Citigroup Global Markets Inc., J.P. Morgan Securities LLC and Wells Fargo Securities, LLC, on behalf of themselves and as representatives of the initial purchasers, relating to the 5.50% First Priority Senior Secured Notes due 2028
(incorporated by reference to Exhibit 4.2 to the Company’s Current Report on Form 8-K filed on March 30, 2023).
|
||
|
22.1*
|
Subsidiary Guarantors.
|
|
|
31.1*
|
Rule 13a-14(a)/15d-14(a) Certification of the Chief Executive Officer.
|
|
|
31.2*
|
Rule 13a-14(a)/15d-14(a) Certification of the Chief Financial Officer.
|
|
|
32.1**
|
Section 1350 Certification of the Chief Executive Officer.
|
|
|
32.2**
|
Section 1350 Certification of the Chief Financial Officer.
|
|
|
101.INS
|
Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline
XBRL document).
|
|
|
101.SCH
|
Inline XBRL Taxonomy Extension Schema Document.
|
|
|
101.CAL
|
Inline XBRL Taxonomy Extension Calculation Linkbase Document.
|
|
|
101.DEF
|
Inline XBRL Taxonomy Extension Definition Linkbase Document.
|
|
|
101.LAB
|
Inline XBRL Taxonomy Extension Label Linkbase Document.
|
|
|
101.PRE
|
Inline XBRL Taxonomy Extension Presentation Linkbase Document.
|
|
|
104
|
Cover Page Interactive Date File (formatted as Inline XBRL and contained in Exhibit 101).
|
| * |
Filed herewith
|
| ** |
Furnished herewith
|
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
|
Berry Global Group, Inc.
|
|||
|
May 4, 2023
|
By:
|
/s/ Mark W. Miles
|
|
|
Mark W. Miles
|
|||
|
Chief Financial Officer
|
|||